Catenacci DV, et al. J. Clin. Oncol. (2015) cited as Ref 607 in DOI: 10.1038/s41392-020-0110-5 (Q9870)

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Catenacci DV, et al. J. Clin. Oncol. (2015) cited as Ref 607 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Catenacci DV
    0 references
    0 references
    2015
    0 references
    J. Clin. Oncol.
    0 references
    33
    0 references
    Randomized phase Ib/II study of gemcitabine plus placebo or vismodegib a hedgehog pathway inhibitor in patients with metastatic pancreatic cancer (English)
    0 references
    4284-4292
    0 references